Phase I Human Analytics (HALO) Study
Part of paid clinical trials in Indian Wells, California.
- Sponsor
- HALO Diagnostics
- Study ID
- NCT05423860
- Status
- Recruiting
Conditions
- Cancer
- Cardiovascular Diseases
- Dementia
- Traumatic Brain Injury
Eligibility Criteria
- Sex
- MALE
- Age
- 45 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- no interventions will be performed (observational) — OTHERNot applicable. (no interventions will be performed with this observational study
Study Details
Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clinical states, in preclinical states, and to develop ensemble multivariate biomarker risk scores leading to cardiovascular, oncologic, neurologic, and other diseases and disorders. Additionally, the study aims to: * Evaluate data analysis techniques to improve diagnostic accuracy and reduce time to diagnosis. * Evaluate data analysis techniques to improve risk stratification for participants through machine learning algorithms. * Direct participants to relevant and applicable clinical trials.
Key Dates
- Start date
- Mar 16, 2022
- Status verified
- Oct 2022
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2037
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: dementiaPatients with a diagnosis of dementia
- Arm: Prostate cancerpatients with a diagnosis of prostate cancer
- Arm: breast cancerPatients with a diagnosis of breast cancer
- Arm: NormalPatients without a diagnosis
- Arm: tramatic brain injurypatients with a diagnosis of traumatic brain injury
Primary Outcome Measure
Prostate cancer Gleason score [ Time Frame: Up to 5 years after treatment ]
Central Contacts
- Christopher R Hancock, MD,MBA760-776-8989
- Erik W Peterson414-745-5773
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Desert Medical Imaging | Indian Wells | California | 92210 | Bernadette M. Greenwood, MSc 760-766-2047 Chris R Hancock, MD (PRINCIPAL_INVESTIGATOR) Bernadette M. Greenwood, BSc (SUB_INVESTIGATOR) Erik W Peterson, BS (SUB_INVESTIGATOR) |
Find similar trials in Indian Wells, CA
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With CancerPHASE1/PHASE2 · Recruiting · Heike E Daldrup-Link · Stanford, California
- Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and TreatmentRecruiting · MiraKind · Los Angeles, California
- Hyperbaric Oxygen Brain Injury Treatment TrialPHASE2 · Recruiting · Gaylan Rockswold · San Diego, California